Corvus Pharmaceuticals, Inc. (CRVS)
18.76
-0.98
(-4.96%)
USD |
NASDAQ |
Feb 12, 16:00
18.73
-0.03
(-0.16%)
After-Hours: 04:35
Corvus Pharmaceuticals Free Cash Flow : -32.22M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Geron Corp. | -132.68M |
| Jaguar Health, Inc. | -26.29M |
| Krystal Biotech, Inc. | 165.59M |
| Rapt Therapeutics, Inc. | -86.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.566M |
| Cash from Investing (Quarterly) | -2.618M |
| Cash from Financing (Quarterly) | 0.36M |
| Free Cash Flow Per Share (Quarterly) | -0.1155 |
| Free Cash Flow to Equity (Quarterly) | -9.494M |
| Free Cash Flow to Firm (Quarterly) | -9.566M |
| Free Cash Flow Yield | -2.26% |